Neuralink’s China rival targets obesity With ‘electronic’ GLP-1Neuralink的中国竞争对手瞄准肥胖问题,推出“电子”GLP-1
Chinese neurotechnology firm BrainCo is developing a wearable device that it says could suppress appetite by stimulating the brain.

BrainCo – which seeks to compete with Elon Musk’s Neuralink – is aiming to apply its brain-computer interface, or BCI, technology for the weight-loss market. — Image by Magnific
Chinese neurotechnology firm BrainCo is developing a wearable device that it says could suppress appetite by stimulating the brain, positioning it as a potential non-drug alternative to blockbuster GLP-1 weight-loss treatments.
The company aims to bring the device to market within the next two to three years, according to founding partner Nyx He, who spoke in an interview at Bloomberg Tech London event.
Why brain implants are more than a sci-fi fantasy
China approves string of ‘telepathy’ devices amid push to leapfrog Elon Musk
US brain implant company tests with patients in China
Thank you for your report!
Technology refresh to bolster Hartalega showing
Copper falls as technology rout and oil surge fuel growth fears
Advance Technologies signs underwriting agreement for ACE Market IPO
BrainCo公司旨在与埃隆·马斯克的Neuralink公司竞争,其目标是将脑机接口(BCI)技术应用于减肥市场。——图片来自Magnific
中国神经技术公司 BrainCo 正在开发一种可穿戴设备,该公司称该设备可以通过刺激大脑来抑制食欲,使其成为重磅 GLP-1 减肥疗法的潜在非药物替代品。
据创始合伙人 Nyx He 在彭博伦敦科技活动上接受采访时表示,该公司计划在未来两到三年内将该设备推向市场。
为什么脑植入不仅仅是科幻幻想
中国批准了一系列“心灵感应”设备,力图超越埃隆·马斯克。
美国脑植入公司在中国进行患者测试
感谢您的报告!
技术升级将提升 Hartalega 的表现
受科技股暴跌和油价飙升引发的经济增长担忧影响,铜价下跌。
Advance Technologies签署ACE市场IPO承销协议